Aim This study aimed to evaluate the label compliance of DOACs in the Chinese AF
population and explore the relationship between inappropriate DOACs dosage and clinical …

Background: Off-label dosing of direct oral anticoagulants (DOACs) is encountered clinically
among patients with atrial fibrillation (AF), although data on the clinical outcomes of over …

Background: In routine clinical practice, non-standard doses of direct oral anticoagulants
(DOACs) are commonly used in patients with atrial fibrillation (AF). However, data on the …

Background Several observational studies have shown that the inappropriate dosing use of
direct oral anticoagulants (DOACs) in atrial fibrillation (AF) that does not conform to …

Introduction Off-label, under-, and overdosed direct oral anticoagulants (DOACs) are
commonly prescribed to patients with atrial fibrillation (AF), but real-world evidence on their …

Background Direct oral anticoagulants (DOACs) are commonly used to prevent stroke and
systemic embolism in patients with atrial fibrillation (AF). However, studies into their …

Background: Prescriptions of off-label under-and overdosing of direct oral anticoagulants
(DOACs) are common for patients with atrial fibrillation, but their efficacy and safety remain …

Abstract Background Direct oral anticoagulants (DOACs) reduce the risk of stroke and
systemic embolism in patients with nonvalvular atrial fibrillation but may result in serious …

The present study aimed to assess the associations between dosing of DOACs and
outcomes in patients with non-valvular atrial fibrillation (NVAF). Direct oral anticoagulants …

Purpose To compare the effectiveness and safety of reduced or standard daily doses of
direct oral anticoagulants (DOACs) with warfarin in Japanese patients with nonvalvular atrial …